Free Trial

Genus (LON:GNS) Sets New 1-Year High - Here's Why

Genus logo with Medical background

Key Points

  • Genus plc (LON:GNS) reached a new 52-week high, trading at GBX 2,555 ($34.70) with a trading volume of 26,821 shares.
  • Analysts from Deutsche Bank raised their price target for Genus shares to GBX 2,550 ($34.63) and reiterated a "buy" rating.
  • The company's market capitalization stands at £1.67 billion with a notably high price-to-earnings ratio of 211.79.
  • Looking to export and analyze Genus data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Genus plc (LON:GNS - Get Free Report) reached a new 52-week high during trading on Thursday . The company traded as high as GBX 2,555 ($34.65) and last traded at GBX 2,555 ($34.65), with a volume of 26821 shares trading hands. The stock had previously closed at GBX 2,540 ($34.45).

Analyst Ratings Changes

A number of research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Genus from GBX 2,250 ($30.51) to GBX 2,550 ($34.58) and gave the company a "buy" rating in a research note on Tuesday, July 15th. Shore Capital reiterated a "buy" rating and set a GBX 2,750 ($37.29) price objective on shares of Genus in a research note on Tuesday, July 15th.

Get Our Latest Analysis on Genus

Genus Stock Up 0.8%

The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The stock has a market capitalization of £1.70 billion, a P/E ratio of 214.69, a P/E/G ratio of 2.87 and a beta of 0.37. The stock's 50 day simple moving average is GBX 2,249.52 and its 200 day simple moving average is GBX 2,001.10.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Further Reading

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines